000 02019 a2200565 4500
005 20250516213538.0
264 0 _c20150512
008 201505s 0 0 eng d
022 _a1473-5741
024 7 _a10.1097/CAD.0000000000000126
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCéruse, Philippe
245 0 0 _aA pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
_h[electronic resource]
260 _bAnti-cancer drugs
_cSep 2014
300 _a970-5 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCarcinoma, Squamous Cell
_xdrug therapy
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aDocetaxel
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInduction Chemotherapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aOrgan Sparing Treatments
650 0 4 _aParanasal Sinus Neoplasms
_xdrug therapy
650 0 4 _aPyriform Sinus
_xpathology
650 0 4 _aRetrospective Studies
650 0 4 _aTaxoids
_xadministration & dosage
700 1 _aCosmidis, Alain
700 1 _aBelot, Aurélien
700 1 _aRabilloud, Muriel
700 1 _aFuchsmann, Carine
700 1 _aPoupart, Marc
700 1 _aRamade, Antoine
700 1 _aTartas, Sophie
700 1 _aFavrel, Véronique
700 1 _aPommier, Pascal
700 1 _aZrounba, Philippe
700 1 _aFayette, Jérôme
773 0 _tAnti-cancer drugs
_gvol. 25
_gno. 8
_gp. 970-5
856 4 0 _uhttps://doi.org/10.1097/CAD.0000000000000126
_zAvailable from publisher's website
999 _c23845745
_d23845745